Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorHERNÁNDEZ-RUIZ, Virgilio
dc.contributor.authorFORESTIER, Emmanuel
dc.contributor.authorGAVAZZI, Gaëtan
dc.contributor.authorFERRY, Tristan
dc.contributor.authorGRÉGOIRE, Nicolas
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorBREILH, Dominique
dc.contributor.authorPACCALIN, Marc
dc.contributor.authorGOUTELLE, Sylvain
dc.contributor.authorROUBAUD-BAUDRON, Claire
dc.date.accessioned2021-02-02T16:25:42Z
dc.date.available2021-02-02T16:25:42Z
dc.date.issued2021-01-01
dc.identifier.issn1538-9375en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26117
dc.description.abstractEnTo describe the rationale for subcutaneous (SC) administration of antibiotics from available published data and to make propositions to help clinicians in daily practice. Narrative review. Hospitalized patients, persons in long-term care facilities and ambulatory care. We searched the MEDLINE/PubMed electronic database for evidence supporting SC administration of antibiotics up to September 2019; the results of this primary search were supplemented by searching the references of the identified articles, as well as by searching in Google Scholar. Regarding tolerability, efficacy, and pharmacokinetic/pharmacodynamic profiles, most studies suggest that the SC route could be an alternative to the intravenous route, particularly for time-dependent antibiotics and among certain patient populations, such as patients with poor venous access, swallowing disorders, or behavioral disturbance. However, clinical evidence of the benefits and risks of SC antibiotic administration is still scarce and of low level. SC administration of antibiotics may be useful in various settings such as in hospitalized patients and among those in long-term care facilities or being cared for at home. However, further clinical studies are needed to assess the pharmacokinetic/pharmacodynamic properties, as well as the risks and benefits of SC administration of antibiotics. In this review, we highlight the potential benefits of SC administration of antibiotics and address practical recommendations for its use. This information will enable improvement of treatment strategies and present the SC route as a potential option in specific situations.
dc.language.isoENen_US
dc.subject.enSubcutaneous
dc.subject.ensubcutaneously administered
dc.subject.enantibiotics
dc.subject.enantimicrobials
dc.title.enSubcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When
dc.title.alternativeJ Am Med Dir Assocen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jamda.2020.04.035en_US
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologie
dc.identifier.pubmed32674952en_US
bordeaux.journalJournal of the American Medical Directors Associationen_US
bordeaux.page50-55.e6en_US
bordeaux.volume22en_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires - U1034en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-03194481
hal.version1
hal.date.transferred2021-04-09T13:30:58Z
hal.exporttrue
workflow.import.sourcepubmed
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal%20of%20the%20American%20Medical%20Directors%20Association&rft.date=2021-01-01&rft.volume=22&rft.issue=1&rft.spage=50-55.e6&rft.epage=50-55.e6&rft.eissn=1538-9375&rft.issn=1538-9375&rft.au=HERN%C3%81NDEZ-RUIZ,%20Virgilio&FORESTIER,%20Emmanuel&GAVAZZI,%20Ga%C3%ABtan&FERRY,%20Tristan&GR%C3%89GOIRE,%20Nicolas&rft.genre=article


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record